retatrutide phase 2 trial results weight loss obesity triple agonist This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #Endocrinology Weight loss with retatrutide as
Description
Monami M, Marchionni N, Mannucci E (2009) Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
Beyond weight loss, TRIUMPH-4 also measured pain and physical function in participants with knee osteoarthritis
Plenty look great at first
The clinical trial protocols provide a framework that researchers have adapted based on individual tolerability and response patterns
Should I stop retatrutide if I have diarrhea
